Nyxoah SA NYXH
Set alert
0.87 USD -0.02 -1.85%
At close · Oct 30
0.87 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
0.87 Day range 0.93
0.822 52-week range 5.89
- YTD
- -81.05%
- 1 year
- -82.67%
- Open
- 0.8808
- Prev close
- 0.8879
- Mkt cap
- 88.75M
- Vol
- 157.84K
- Avg vol
- 310.55K
- EPS
- -2.56
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.87
- High
- 0.93
- Forward P/E
- -5.03
- Beta
- 0.55
- Short ratio
- 2.45
- Inst. own
- 35.37%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 8.73
- 200-d avg
- 9.37
- 1y target
- 15.60
2Y chart
Events in this range
- Nov 5, 2024Rating: Cantor Fitzgerald · Overweight → Overweight
- Nov 6, 2024Earnings: -0.55; estimate -0.46; surprise -19.57%
- Dec 13, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (76)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 29, 2026 | 2 days ago |
| RSI: Oversold | Oct 19, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 3, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| RSI: Oversold | Aug 6, 2026 | 2 months ago |
| RSI: Oversold | Jul 24, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 5, 2026 | 4 months ago |
| RSI: Oversold | Jun 5, 2026 | 4 months ago |
| MACD: Buy Signal | May 29, 2026 | 5 months ago |
| MACD: Sell Signal | May 19, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
| SMA: Bullish | May 8, 2026 | 5 months ago |
| MACD: Buy Signal | May 5, 2026 | 5 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 30, 2026 | 7 months ago |
| RSI: Oversold | Mar 27, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 25, 2026 | 7 months ago |
| RSI: Oversold | Mar 13, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 27, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 26, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 19, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 19, 2026 | 8 months ago |
| SMA: Bullish | Feb 18, 2026 | 8 months ago |
| SMA: Bearish | Jan 30, 2026 | 9 months ago |
| SMA: Bullish | Jan 28, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 21, 2026 | 9 months ago |
| SMA: Bearish | Jan 20, 2026 | 9 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 5, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 26, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 1, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bullish | Nov 11, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 11, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 23, 2025 | 1 year ago |
| SMA: Bullish | Oct 7, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 30, 2025 | 1 year ago |
| RSI: Oversold | Sep 25, 2025 | 1 year ago |
| RSI: Oversold | Sep 12, 2025 | 1 year ago |
| SMA: Bearish | Jul 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 16, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 12, 2025 | 1 year ago |
| RSI: Overbought | May 21, 2025 | 1 year ago |
| SMA: Bullish | May 20, 2025 | 1 year ago |
| RSI: Oversold | Apr 25, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 21, 2025 | 1 year ago |
| RSI: Oversold | Apr 14, 2025 | 1 year ago |
| RSI: Oversold | Mar 27, 2025 | 1 year ago |
| SMA: Bearish | Mar 26, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 26, 2025 | 1 year ago |
| SMA: Bullish | Mar 14, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 14, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 30, 2025 | 1 year ago |
| RSI: Overbought | Jan 24, 2025 | 1 year ago |
| RSI: Overbought | Jan 15, 2025 | 1 year ago |
| RSI: Overbought | Jan 2, 2025 | 1 year ago |
| RSI: Oversold | Dec 9, 2024 | 1 year ago |
| RSI: Oversold | Dec 5, 2024 | 1 year ago |
| RSI: Oversold | Nov 22, 2024 | 1 year ago |
Key statistics
- Market cap
- 303.31M
- Enterprise value
- 227.81M
- Trailing P/E
- 0.00
- Forward P/E
- -5.03
- PEG ratio
- 0.00
- Price / sales
- 59.68
- Price / book
- 2.63
- EPS (TTM)
- -1.81
- Beta
- 0.55
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 5.08M
- Revenue growth
- 29.70%
- Free cash flow
- -35.99M
- Total cash
- 70.98M
- Total debt
- 23.33M
- Return on equity
- -49.69%
- Shares outstanding
- 37.43M
- Short % of float
- 0.32%
- 50-day average
- 8.73
- 200-day average
- 9.37
Analyst view
Consensus: buy
Buy
Price target (mean) 15.60 +1690.0% upside
Now 0.8715
- Target (low)
- 12.61
- Target (mean)
- 15.60
- Target (high)
- 17.46
Ratings (0m) 6 5 buy · 1 hold · 0 sell
- Strong buy2
- Buy3
- Hold1
- Sell0
- Strong sell0
Next earnings
Aug 6, 2024
Expected Aug 6, 2024. Consensus EPS estimate -0.4384.
Financials — quick view
NYXH Revenue — quarterly 7.67M
NYXH Net income — quarterly -32.96M
NYXH EPS — quarterly -0.578
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | -0.46 | -0.55 | -0.09 | -19.57% |
| Aug 6, 2024 | Jun 1, 2024 | -0.45 | — | — | — |
| Aug 6, 2024 | Jun 1, 2024 | -0.45 | -0.46 | -0.01 | -2.22% |
| May 14, 2024 | Mar 1, 2024 | -0.45 | -0.45 | 0.00 | 0.00% |
| May 14, 2024 | Mar 1, 2024 | -0.45 | — | — | — |
| Mar 5, 2024 | Dec 1, 2023 | -0.41 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 13, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Nov 5, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Oct 11, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Sep 30, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 7, 2024 | Cantor Fitzgerald | main | Overweight | Overweight |
| Aug 7, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
About Nyxoah SA
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Belgium
- Website
- nyxoah.com
News
- Cantor Fitzgerald Maintains Overweight on Nyxoah, Lowers Price Target to $3
- Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
- Why RingCentral Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
- Here's Why Nyxoah (NYXH) Could be Great Choice for a Bottom Fisher
- Nyxoah Reports Preliminary Q3 Global Net Sales Of ~€9.2M, Up 19% QoQ; Lowers FY26 Global Net Sales From €36M-€40M To €33M-€35M
- Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026
- Contrasting Nephros (NASDAQ:NEPH) & Nyxoah (NASDAQ:NYXH)
- Nyxoah: Label Expansion Set To Unlock A Monopoly In A Billion Dollar Market.
- Nyxoah Appoints Liam Kelly as Chief Executive Officer
- 12 Health Care Stocks Moving In Friday's Intraday Session
Your note
Sign in to keep a note on NYXH — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 4.99% | 1,715,125 | 13.72M | Sep 29, 2024 |
| Blackrock Inc. | 3.45% | 1,186,093 | 9.49M | Sep 29, 2024 |
| Franklin Resources, Inc. | 0.85% | 292,570 | 2.34M | Sep 29, 2024 |
| Millennium Management Llc | 0.55% | 187,367 | 1.50M | Sep 29, 2024 |
| CVI Holdings, LLC | 0.53% | 183,590 | 1.47M | Jun 29, 2024 |
| AXA S.A. | 0.44% | 152,000 | 1.22M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Small Cap Growth Fund | 1.94% | 667,557 | 5.34M | Aug 30, 2024 |
| BlackRock Health Sciences Term Trust | 1.89% | 648,041 | 5.18M | Sep 29, 2024 |
| Fidelity Select Portfolios - Pharmaceuticals | 1.39% | 479,065 | 3.83M | Oct 30, 2024 |
| Blackrock Funds-Health Sciences Opportunity Portfolio | 1.20% | 411,250 | 3.29M | Aug 30, 2024 |
| Fidelity Central Investment Port-International Equity Central Fd | 0.98% | 335,700 | 2.69M | Sep 29, 2024 |
| Putnam Fds Tr-Putnam Multi Cap Core Fd | 0.82% | 282,458 | 2.26M | Jul 30, 2024 |